The Recall Desk
ModerateFDA (Drugs)·D-0230-2024·Announced 2024-01-24

Freskaro Magnesium Citrate oral solution recalled for bacterial contamination

Pharma Nobis LLC is recalling Freskaro Magnesium Citrate Oral Solution (Grape Flavor) nationwide due to the presence of Acetobacter nitrogenifigens bacteria.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: FDA Class II recall with no reported illnesses or hospitalizations. Acetobacter nitrogenifigens is not a high-risk pathogen, and the absence of reported illness cases places this in the Moderate severity category.

Plain-English summary

Pharma Nobis LLC is recalling Freskaro Magnesium Citrate Oral Solution (Grape Flavor), an over-the-counter saline laxative, due to the presence of Acetobacter nitrogenifigens bacteria. The affected lot is A80553 with an expiration date of November 2025. Approximately 53,268 bottles were distributed nationwide.

This is an FDA Class II recall, which indicates a serious potential health hazard. The recall addresses microbial contamination in this non-sterile product.

Consumers with questions about this recall should contact Pharma Nobis LLC or the FDA.

The recalled product

Product
MAGNESIUM CITRATE (FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE)
Brand
MAGNESIUM CITRATE
Manufacturer
Pharma Nobis LLC
Hazard
  • bacterial-contamination
  • acetobacter

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot A80553
  • Exp. 11/2025

UPCs (1)

  • 0382645311100

Distribution

Distributed nationwide across the United States.